Dáil Éireann Debate, Thursday - 11 February 2021
268. Deputy Colm Burke asked the Minister for Health if a list of the rare disease technology review committee recommendations in 2020 will be made available in tabular form; and if he will make a statement on the matter. [7590/21]
View answerThe HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
